DEDI.ST
Dedicare AB (publ) [DEDI.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DEDI.ST Stock Summary
Top 10 Correlated ETFs
DEDI.ST
Top 10 Correlated Stocks
DEDI.ST
In the News
DEDI.ST Financial details
Company Rating
Buy
Market Cap
981.14M
Income
110.3M
Revenue
1.97B
Book val./share
32.41
Cash/share
19.57
Dividend
6
Dividend %
5.41%
Employees
1.33K
Optionable
No
Shortable
Yes
Earnings
18 Apr 2024
P/E
10.43
Forward P/E
-
PEG
11.88
P/S
0.56
P/B
3.72
P/C
5.12
P/FCF
6.73
Quick Ratio
0.41
Current Ratio
1.44
Debt / Equity
0.28
LT Debt / Equity
0.1
-
-
EPS (TTM)
11.52
EPS next Y
-
EPS next Q
-
EPS this Y
9.07%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
31.66%
Revenue last 5Y
20.49%
Revenue Q/Q
-11.52%
EPS Q/Q
15.41%
-
-
-
-
SMA20
1%
SMA50
-6.48%
SMA100
-2.88%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
37%
ROC
0.38%
Gross Margin
29%
Oper. Margin
7%
Profit Margin
5%
Payout
56%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
79.5-156.0
52W High
-35.77%
52W Low
+26.84%
RSI
48
Rel Volume
0.34
Avg Volume
32.55K
Volume
11.16K
Perf Week
-2.15%
Perf Month
4.16%
Perf Quarter
7.05%
Perf Half Y
22.34%
-
-
-
-
Beta
0.728
-
-
Volatility
0.91%, 1.8%
Prev Close
0%
Price
100.2
Change
0.3%
DEDI.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 85.69 | 95.08 | 133.03 | 184.89 | 206.08 | |
| Net income per share | 2.92 | 3.87 | 6.98 | 10.59 | 11.55 | |
| Operating cash flow per share | 5.19 | 4.31 | 7.41 | 11.02 | 15.2 | |
| Free cash flow per share | 4.99 | 4.03 | 7.16 | 10.45 | 14.73 | |
| Cash per share | 6.92 | 10.77 | 14.09 | 14.93 | 19.57 | |
| Book value per share | 10.28 | 14.55 | 19 | 27.46 | 32.41 | |
| Tangible book value per share | 9.15 | 5.81 | 10.64 | 9.57 | 15.14 | |
| Share holders equity per share | 10.28 | 14.55 | 19 | 27.46 | 32.41 | |
| Interest debt per share | 1.73 | 4.65 | 3.76 | 12.53 | 9.95 | |
| Market cap | 370.37M | 354.73M | 646.4M | 1.17B | 1.09B | |
| Enterprise value | 322.25M | 295.36M | 547.53M | 1.14B | 992.87M | |
| P/E ratio | 14.01 | 9.84 | 9.86 | 11.52 | 9.89 | |
| Price to sales ratio | 0.48 | 0.4 | 0.52 | 0.66 | 0.55 | |
| POCF ratio | 7.89 | 8.84 | 9.29 | 11.08 | 7.51 | |
| PFCF ratio | 8.19 | 9.45 | 9.6 | 11.67 | 7.75 | |
| P/B Ratio | 3.98 | 2.62 | 3.62 | 4.44 | 3.52 | |
| PTB ratio | 3.98 | 2.62 | 3.62 | 4.44 | 3.52 | |
| EV to sales | 0.42 | 0.33 | 0.44 | 0.64 | 0.5 | |
| Enterprise value over EBITDA | 7.68 | 4.81 | 5.35 | 7.38 | 6.18 | |
| EV to operating cash flow | 6.86 | 7.36 | 7.87 | 10.82 | 6.83 | |
| EV to free cash flow | 7.13 | 7.87 | 8.14 | 11.4 | 7.05 | |
| Earnings yield | 0.07 | 0.1 | 0.1 | 0.09 | 0.1 | |
| Free cash flow yield | 0.12 | 0.11 | 0.1 | 0.09 | 0.13 | |
| Debt to equity | 0.16 | 0.3 | 0.19 | 0.44 | 0.28 | |
| Debt to assets | 0.06 | 0.11 | 0.07 | 0.16 | 0.12 | |
| Net debt to EBITDA | -1.15 | -0.97 | -0.97 | -0.17 | -0.62 | |
| Current ratio | 1.66 | 1.69 | 1.63 | 1.47 | 1.43 | |
| Interest coverage | 31.33 | 18.73 | 48.98 | 35.6 | 20.66 | |
| Income quality | 1.33 | 0.92 | 0.79 | 0.78 | 0.98 | |
| Dividend Yield | 0.1 | 0 | 0.04 | 0.03 | 0.05 | |
| Payout ratio | 1.37 | 0 | 0.36 | 0.38 | 0.52 | |
| Sales general and administrative to revenue | 0.08 | 0.08 | 0.08 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.04 | 0.21 | 0.16 | 0.23 | 0.23 | |
| Capex to operating cash flow | -0.04 | -0.06 | -0.03 | -0.05 | -0.03 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.27 | -0.22 | -0.17 | -0.27 | -0.19 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 25.98 | 35.6 | 54.62 | 80.9 | 91.76 | |
| ROIC | 0.22 | 0.18 | 0.3 | 0.26 | 0.28 | |
| Return on tangible assets | 0.12 | 0.12 | 0.16 | 0.18 | 0.2 | |
| Graham Net | 2.65 | -1.41 | 0.82 | -5.51 | 1.86 | |
| Working capital | 82.44M | 115.66M | 154.18M | 171.4M | 160.92M | |
| Tangible asset value | 82.87M | 54.05M | 99.93M | 91.47M | 144.74M | |
| Net current asset value | 61.59M | 34.43M | 81.1M | 56.03M | 115.2M | |
| Invested capital | 0.16 | 0.3 | 0.19 | 0.44 | 0.28 | |
| Average receivables | 71.56M | 159.84M | 218.01M | 319.51M | 355.1M | |
| Average payables | 3.99M | 3.83M | 4.81M | 12.16M | 11.74M | |
| Average inventory | 0 | 3.39M | 3.39M | 1.5 | 1 | |
| Days sales outstanding | 67.32 | 72.8 | 75.78 | 78.35 | 61.25 | |
| Days payables outstanding | 2.65 | 1.33 | 2.73 | 5.15 | 1.54 | |
| Days of inventory on hand | 0 | 3.26 | 0 | 0 | 0 | |
| Receivables turnover | 5.42 | 5.01 | 4.82 | 4.66 | 5.96 | |
| Payables turnover | 137.62 | 273.46 | 133.54 | 70.83 | 236.63 | |
| Inventory turnover | 0 | 112.11 | 456.24M | 1.24B | 1.42B | |
| ROE | 0.28 | 0.27 | 0.37 | 0.39 | 0.36 | |
| Capex per share | -0.19 | -0.28 | -0.24 | -0.56 | -0.47 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 52.33 | 52.62 | 50.08 | 54.85 | 48.53 | |
| Net income per share | 2.64 | 2.56 | 2.39 | 3.05 | 3.52 | |
| Operating cash flow per share | 8.59 | 4.37 | 0.99 | 4.01 | 5.83 | |
| Free cash flow per share | 8.43 | 4.2 | 0.87 | 3.95 | 5.69 | |
| Cash per share | 14.97 | 17.14 | 11.72 | 15.16 | 19.57 | |
| Book value per share | 27.52 | 29.81 | 27.14 | 29.85 | 32.41 | |
| Tangible book value per share | 9.59 | 11.56 | 8.67 | 12.06 | 15.14 | |
| Share holders equity per share | 27.52 | 29.81 | 27.14 | 29.85 | 32.41 | |
| Interest debt per share | 12.13 | 9.85 | 9.53 | 6.78 | 9.2 | |
| Market cap | 1.16B | 1.38B | 1.14B | 848.21M | 1.09B | |
| Enterprise value | 1.14B | 1.3B | 1.11B | 767.51M | 992.87M | |
| P/E ratio | 11.55 | 14.05 | 12.42 | 7.26 | 8.1 | |
| Price to sales ratio | 2.33 | 2.74 | 2.38 | 1.62 | 2.35 | |
| POCF ratio | 14.21 | 32.94 | 119.78 | 22.15 | 19.57 | |
| PFCF ratio | 14.47 | 34.25 | 137.1 | 22.44 | 20.05 | |
| P/B Ratio | 4.43 | 4.83 | 4.39 | 2.97 | 3.52 | |
| PTB ratio | 4.43 | 4.83 | 4.39 | 2.97 | 3.52 | |
| EV to sales | 2.28 | 2.58 | 2.32 | 1.46 | 2.14 | |
| Enterprise value over EBITDA | 31.35 | 29.43 | 27.33 | 17.56 | 23.19 | |
| EV to operating cash flow | 13.88 | 31.12 | 117.09 | 20.04 | 17.79 | |
| EV to free cash flow | 14.13 | 32.35 | 134.02 | 20.3 | 18.23 | |
| Earnings yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Free cash flow yield | 0.07 | 0.03 | 0.01 | 0.04 | 0.05 | |
| Debt to equity | 0.44 | 0.31 | 0.33 | 0.23 | 0.28 | |
| Debt to assets | 0.16 | 0.12 | 0.12 | 0.09 | 0.12 | |
| Net debt to EBITDA | -0.74 | -1.73 | -0.63 | -1.85 | -2.32 | |
| Current ratio | 1.47 | 1.52 | 1.44 | 1.44 | 1.43 | |
| Interest coverage | -111.39 | 5.67 | 7.48 | 73.4 | 0 | |
| Income quality | 3.25 | 1.71 | 0.41 | 1.31 | 1.66 | |
| Dividend Yield | 0 | 0 | 0.05 | 0 | 0 | |
| Payout ratio | 0 | 0 | 2.51 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.23 | 0.23 | 0.25 | 0.23 | 0.23 | |
| Capex to operating cash flow | -0.02 | -0.04 | -0.13 | -0.01 | -0.02 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.22 | -0.26 | -0.19 | -0.07 | -0.28 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 40.44 | 41.46 | 38.24 | 45.28 | 50.7 | |
| ROIC | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | |
| Return on tangible assets | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | |
| Graham Net | -5.52 | -2.03 | -5.47 | -2.1 | 1.86 | |
| Working capital | 171.4M | 183.3M | 149.8M | 157.4M | 160.92M | |
| Tangible asset value | 91.47M | 110.5M | 82.9M | 115.3M | 144.74M | |
| Net current asset value | 56.03M | 73.7M | 41.5M | 72.1M | 115.2M | |
| Invested capital | 0.44 | 0.31 | 0.33 | 0.23 | 0.28 | |
| Average receivables | 379.27M | 376.02M | 373.9M | 372M | 349.69M | |
| Average payables | 8.74M | 8.74M | 0 | 0 | 3M | |
| Average inventory | -189.5M | 0.5 | 0 | 0 | 0.5 | |
| Days sales outstanding | 68.41 | 66.62 | 70.53 | 63.27 | 64.13 | |
| Days payables outstanding | 8.02 | 0 | 0 | 0 | 2.95 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 1.32 | 1.35 | 1.28 | 1.42 | 1.4 | |
| Payables turnover | 11.23 | 0 | 0 | 0 | 30.49 | |
| Inventory turnover | 196.29M | 0 | 6566602.34B | 7272923.14B | 182.71M | |
| ROE | 0.1 | 0.09 | 0.09 | 0.1 | 0.11 | |
| Capex per share | -0.15 | -0.17 | -0.13 | -0.05 | -0.14 |
DEDI.ST Frequently Asked Questions
What is Dedicare AB (publ) stock symbol ?
Dedicare AB (publ) is a SE stock and trading under the symbol DEDI.ST
What is Dedicare AB (publ) stock quote today ?
Dedicare AB (publ) stock price is $100.2 today.
Is Dedicare AB (publ) stock public?
Yes, Dedicare AB (publ) is a publicly traded company.
Company Profile
- Volume Average 32.55K
- Market Capitalization 981.14M
- Employee 1.33K
- CEO Mr. Krister Widstrom
- Headquarters Stockholm,SE
- IPO Date 2011-05-04
-
Website
https://www.dedicare.se 
Dedicare AB (publ) operates as a staffing company in the healthcare industry primarily in Sweden, Norway, Finland, and Denmark. The company hires and recruits doctors, nurses, social workers, and managers, as well as other staff in health and social work. It provides individual temporary staffing, as well as department, unit, or operations team staffing services. The company was founded in 1996 and is headquartered in Stockholm, Sweden.
